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Background: Nutritional deficiency, bleeding, and inflammation are three main causes of anemia. On the other hand, erythropoietin (EPO) production, iron availability, and a healthy bone marrow are essential for erythropoiesis. Recently, recombinant human erythropoietin (rhEPO) has been used to treat the patients already taking iron supplements. In Iranian traditional medicine literature, much has been written about anemia and its treatment.
Objectives: This study aimed to review Iranian traditional medicine theories in the treatment of anemia.
Materials and Methods: In the present study, authors have attempted to find the etiology and pathogenesis of anemia in Iranian traditional Medicine Literature and the views of ancient physicians in this field.
Results: Our findings proved that Iranian traditional medicine defined anemia as blood humor production dysfunction, which is caused by several reasons mainly hepatic dysfunction. Thus, liver is supposed to be the most important organ in this regard. This will make considering hepatoprotective medicines in anemia even in patients with non-hepatic problems.
Conclusions: The article presents the relation between anemia and liver dysfunction viewed by Iranian traditional medicine as an important finding in designing a treatment plan. Despite the new findings on the evaluation of liver function (i.e. laboratory tests), it seems that further studies for earlier evaluation of liver function in anemia are highly required.
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1. BackgroundOxygen is essential for tissue metabolism and also af-fects the production of erythropoietin in kidneys, which induce red blood cell production in bone marrow. This confirms the key role of oxygen in hematopoiesis regula-tion (1). About 90% of anemic cases are caused by three main reasons: nutritional deficiencies, chronic disease, and bleedings (2). Production of erythropoietin (EPO), adequate iron, and a healthy bone marrow are essential factors for erythropoiesis (3). Recently, erythropoietic agents (as effective nephroprotectives) are being used to treat anemia caused by chronic inflammatory disorders. Also intravenous iron supplements are added to maxi-mize the effect (1, 4). Iranian traditional medicine schol-ars and physicians described anemia as the blood humor (a moist and fluid substance into which aliment is first transformed and it is hot and moist by nature) deficiency and call it Qillat-o-dam (5, 6).
1.1. Blood and Blood HumorThe mechanism of humor production in the liver is briefly presented as follows. When food enters into the stomach, it is converted to a substance called Chylos (a fluid substance resembling thick barely water, result of 
the food digestion for the first time and it is different from the chylos, which passes through the lymphatic veins), which is then ready to be delivered into the liver (5, 7). Chylos tenuity is absorbed in the liver by mesen-teric vessels, then it maturates in the liver and becomes humors (5, 7). Generally, liver is responsible for humors production, especially blood humors, to feed the whole body (5, 7). This shows the critical function of liver in blood humor formation. Likewise, Jorjani (1042-1137 AD) mentioned in his book, Zakhireh Kharazmshahi: "Liver is the principal organ or source of physical faculties" (5). There are three factors affecting the blood humor pro-duction by liver: 1) hepatic equable heat (normal hepatic temperament), 2) proper and equable food and bever-ages from temperamental point of view, and 3) adequate maturation of Chylos by stomach. These will make the body being fed and kept warm and moist (5, 7). Body humors imbalance were diagnosed by tradintional phy-sicians through inspecting patient's blood samples and determining the quality and ratio of each humor there.
2. ObjectivesThis study aimed to evaluate Iranian traditional medi-cine theories in the treatment of anemia.
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3. Materials and MethodsIn this study, the authors reviewed the Iranian traditional medicine literature and after comparing the relevant texts, the pathogenesis and etiology of anemia were discussed.
4. ResultsFrom the perspective of Iranian traditional medicine, anemia is directly related to the liver and physical facul-ties.
4.1. Anemia PathophysiologyPhysical faculties (which might nourish the body until the end of life and hasten its growth to its maximum po-tential) play a key role in humors production, especially blood humor. Liver as the source of this faculty converts the nutrients into the resembled intended organ by nutri-tive faculty, (the faculty, which changes the nutriment into the likeness of the nourished organ and makes up for the loss) a branch of physical faculty (7). This process is dam-aged in three ways. First, conversion of food to humors, mainly blood, which is finely produced in the liver (5, 7) can be interrupted by three factors: 1) gastric digestive fac-ulty dysfunction, 2) hepatic digestive faculty dysfunction, and 3) and absorptive faculty (attracts what is beneficial i.e. nutriment) disorder, which leads to the malnutrition in the organ (called atrophia) (5, 7). It is obvious that liver and stomach digestive faculties function for the whole body.Second, when the nutrient changes into an organ com-ponent. Digestive and expulsive faculties' dysfunction (expulsive faculties, which expels the superfluous matter through the natural passages of orifices) interferes with nutrients becoming an organ’s component, as in anasarca (5, 7).Third, when the nutrient becomes similar to the organ in all aspects, even in texture and color. Sometimes it is inter-fered with, as in vitiligo and leukoderma, when digestive faculty is defected or not functioning properly. This causes the presence of acquisition and adhesion without any re-semblance (5, 7). In conclusion, according to the Iranian tra-ditional medicine, physical faculty’s condition is the most important factor in anemia pathogenesis. However, some of the above disorders like vitiligo, leukoderma, anasarca, and atrophia are not classified under anemia etiology.
4.2. Anemia EtiologyBased on Iranian traditional medicine observations, the basic mechanism of anemia is nutritive faculty dysfunc-tion (5, 7). Therefore, anemia could be associated with both endogenous and exogenous factors classified below.
4.2.1. FoodEating disorders may induce anemia based on their qual-ity and quantity aspects. Malnutrition or taking unsuit-able foods for blood humor may cause anemia (5, 6, 8).
4.2.2. Drugs and ToxinsSome drugs and toxins may cause body temperament to become cool or desiccated. This status prevents blood humor production and may cause anemia (5, 6, 8).
4.2.3. Blood LossSometimes anemia is caused by bleedings such as men-orrhagia, hemorrhoids bleedings, wet cupping, dysen-tery, etc. (5, 6, 8).
4.2.4. Psychological FactorsDepression, horror and the like may interfere with blood humor production through nutritive faculty.
4.2.5. Gastric DisordersGastric disorders such as gastric intemperaments, in-flammations, and digestive disorders may lead to disturb chylos production. This will make liver incapable of pro-ducing excellent blood humor and so anemia occurs (5-7).
4.2.6. Hepatic DiseasesHepatic disorders are classified into two groups.
4.2.6.1. Hepatic Primary DiseasesHepatic disorders such as intemperaments, inflamma-tions, obstructions (Sodad), as well as liver asthenia can lead to hepatic dysfunction. Then anemia will happen as a result of imperfect blood humor production (5, 6).
4.2.6.2. Hepatic Secondary DiseasesMany different factors influence a healthy liver; one of the most important factors is proper functioning of re-lated organs.Stomach, kidney, spleen, and gall bladder disorders af-fect the liver and may cause the most common second-ary hepatic diseases, which lead to anemia. For instance, Jorjani mentioned in his book, Zakhireh Kharazmshahi: “people who suffers from congenital spleen enlarge-ment, are susceptible to liver asthenia, which follows by ascites” (5, 6).Uterus, bowel, lung, and the like may interfere with the liver function but with less significance. For example, se-vere menstruation absorbs the blood from the liver and makes its temperament cold. On the other hand, amenor-rhea may lead to abnormal blood humor production in the liver (5, 6).
5. DiscussionAnemia along with liver diseases such as cirrhosis and chronic liver diseases, especially in association with renal dysfunction, enhances erythropoietin production (9, 10) and there is an inverse correlation between erythropoi-etin and hemoglobin level in chronic hepatic patients (11). But in this situation, erythropoietin level elevation is 
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lower than what observed in iron-deficiency anemia and seems to be inadequate to compensate (10).Currently, recombinant human erythropoietin (rhEPO) is used as a substitute therapy in patients with renal dis-eases, chronic and iron-deficiency anemia (1, 4, 12). Con-sidering the role of EPO in supporting liver regeneration after hepatectomy, its involvement in the regulation of angiogenesis and also the effect of rhEPO in reducing liver injury induced by ischemic reperfusion, this hor-mone seems to have an effective role in liver protection (13-15). There are documents on silymarin effectiveness in anemia as a hepatoprotective medicine, which empha-sizes the importance of hepatic support in anemia (16). Also hepcidin made by hepatocytes blocks cellular iron exportation and is effective in mediating inflammation derived anemia (17, 18). According to Iranian traditional medicine, many pathogenic factors are involved in ane-mia. The most important function in this regard belongs to the liver as a vital organ for both blood humor produc-tion and its regulation.Accordingly, using hepatoprotective medicines are es-sential in treating anemic patients even if there are no signs or symptoms of hepatic diseases. In other words, treating the liver as the producer of blood humor has to be prioritized in these patients in order to correct ane-mia. Then, observing other related organs such as stom-ach, spleen, and gall bladder and treating their disorders is also important. Although there are some reports that aspartate transaminasis to platelet ratio index (APRI) score can be used as a non-invasive marker in liver fibro-sis (19, 20), there might be no compulsion in changing APRI in the process involved liver dysfunction in anemia.Citing from Ibn-Sina’s previous study about anemia, he described the pathophysiology and treatment of many pathological conditions related to anemia such as asci-tes, digestive dysfunction, hepatitis, and so on. He also indicated the different causes for hepatic dysfunction in a logical sequence, which seems to be a very specific sci-entific classification no less different from what we use nowadays. He also mentioned all the organs that contrib-ute to liver asthenia, which lead to anemia.This article presents the relation between anemia and liver dysfunction from Ibn-Sina’s viewpoint, which was an important element in designing a treatment plan. Although there are new findings about the evaluation of liver function in diseases, further studies for earlier evalu-ation of liver function in anemia is highly recommended.
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